217 related articles for article (PubMed ID: 15068904)
21. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
22. [Establishment and characterization of a human acute monocytic leukemic cell line, SHI-1, carrying t(6;11)(q27;23) and p53 gene alteration].
Chen SN; Xue YQ; Zhang XG; Wu YF; Pan JL; Wang Y; Cen JN
Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):94-9. PubMed ID: 15921626
[TBL] [Abstract][Full Text] [Related]
23. [Rearrangements of the mixed lineage leukemia gene in acute myeloid leukemia].
Zhang LJ; Lu XL; He J; Li Y
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2256-60. PubMed ID: 17064570
[TBL] [Abstract][Full Text] [Related]
24. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation.
Rausei-Mills V; Chang KL; Gaal KK; Weiss LM; Huang Q
Am J Clin Pathol; 2008 Apr; 129(4):624-9. PubMed ID: 18343790
[TBL] [Abstract][Full Text] [Related]
25. Multiple and heterogeneous patterns of cytokine production in 18 leukemia and in vitro transformed mature T cell lines reflect the individuality of human leukemias.
Dao T; Holán V; Minowada J
Int J Hematol; 1993 Apr; 57(2):139-46. PubMed ID: 8494992
[TBL] [Abstract][Full Text] [Related]
26. Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells.
Dehmel U; Zaborski M; Meierhoff G; Rosnet O; Birnbaum D; Ludwig WD; Quentmeier H; Drexler HG
Leukemia; 1996 Feb; 10(2):261-70. PubMed ID: 8637235
[TBL] [Abstract][Full Text] [Related]
27. Effects of Flt3 ligand and interleukin-7 on in vitro growth of acute lymphoblastic leukemia cells.
Eder M; Hemmati P; Kalina U; Ottman OG; Hoelzer D; Lyman SD; Ganser A
Exp Hematol; 1996 Feb; 24(2):371-7. PubMed ID: 8641368
[TBL] [Abstract][Full Text] [Related]
28. Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia.
O'Farrell AM; Yuen HA; Smolich B; Hannah AL; Louie SG; Hong W; Stopeck AT; Silverman LR; Lancet JE; Karp JE; Albitar M; Cherrington JM; Giles FJ
Leuk Res; 2004 Jul; 28(7):679-89. PubMed ID: 15158089
[TBL] [Abstract][Full Text] [Related]
29. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
30. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
Wang J; Wang T; Li S; Lin L; Gang Y
Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369
[TBL] [Abstract][Full Text] [Related]
31. KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: two novel mutations and selective occurrence in leukemia subtypes and age groups.
Sritana N; Auewarakul CU
Exp Mol Pathol; 2008 Dec; 85(3):227-31. PubMed ID: 18977345
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor α-Chain (CD25) Expression Predicts a Poor Prognosis.
Nakase K; Kita K; Kyo T; Ueda T; Tanaka I; Katayama N
PLoS One; 2015; 10(9):e0128998. PubMed ID: 26375984
[TBL] [Abstract][Full Text] [Related]
33. Cytokine gene expression and synthesis by human megakaryocytic cells.
Avraham H; Vannier E; Chi SY; Dinarello CA; Groopman JE
Int J Cell Cloning; 1992 Mar; 10(2):70-9. PubMed ID: 1545152
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia.
Kang HJ; Hong SH; Kim IH; Park BK; Han KS; Cho HI; Shin HY; Ahn HS
Leuk Res; 2005 Jun; 29(6):617-23. PubMed ID: 15863200
[TBL] [Abstract][Full Text] [Related]
35. Establishment and characterization of a new human erythroleukemic cell line, ERY-1.
Ribadeau Dumas A; Hamouda NB; Leriche L; Piffaut MC; Bonnemye P; Kuen RL; Tricottet V; Merle-Beral H; N'Guyen Khac F; Arock M
Leuk Res; 2004 Dec; 28(12):1329-39. PubMed ID: 15475075
[TBL] [Abstract][Full Text] [Related]
36. Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations.
Oyarzo MP; Lin P; Glassman A; Bueso-Ramos CE; Luthra R; Medeiros LJ
Am J Clin Pathol; 2004 Sep; 122(3):348-58. PubMed ID: 15362364
[TBL] [Abstract][Full Text] [Related]
37. Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype.
Neben K; Schnittger S; Brors B; Tews B; Kokocinski F; Haferlach T; Müller J; Hahn M; Hiddemann W; Eils R; Lichter P; Schoch C
Oncogene; 2005 Feb; 24(9):1580-8. PubMed ID: 15674343
[TBL] [Abstract][Full Text] [Related]
38. Chemokine expression in human erythroid leukemia cell line AS-E2: macrophage inflammatory protein-3alpha/CCL20 is induced by inflammatory cytokines.
Inoue Y; Tsushima H; Ando K; Sawayama Y; Sakai M; Yamasaki R; Matsuo E; Tsutsumi C; Imaizumi Y; Iwanaga M; Imanishi D; Taguchi J; Miyazaki Y; Tomonaga M
Exp Hematol; 2006 Jan; 34(1):19-26. PubMed ID: 16413387
[TBL] [Abstract][Full Text] [Related]
39. ATRA can enhance apoptosis that is induced by Flt3 tyrosine kinase inhibition in Flt3-ITD positive cells.
Scholl S; Müller R; Clement JH; Loncarevic IF; Böhmer FD; Höffken K
Leuk Res; 2006 May; 30(5):633-42. PubMed ID: 16473406
[TBL] [Abstract][Full Text] [Related]
40. CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemia.
Hoehn D; Medeiros LJ; Chen SS; Tian T; Jorgensen JL; Ahmed Y; Lin P
Am J Clin Pathol; 2012 Feb; 137(2):213-9. PubMed ID: 22261446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]